Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates.
<h4>Background</h4>A pressing need exists to develop vaccines for neglected diseases, including leishmaniasis. However, the development of new vaccines is dependent on their value to two key players-vaccine developers and manufacturers who need to have confidence in the global demand in...
Saved in:
Main Authors: | Sakshi Mohan (Author), Paul Revill (Author), Stefano Malvolti (Author), Melissa Malhame (Author), Mark Sculpher (Author), Paul M Kaye (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human leishmaniasis vaccines: Use cases, target population and potential global demand.
by: Stefano Malvolti, et al.
Published: (2021) -
Estimating the future global dose demand for measles-rubella microarray patches
by: Melissa Ko, et al.
Published: (2023) -
A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates.
by: Freddie Bailey, et al.
Published: (2017) -
Tuberculosis in pregnancy: an estimate of the global burden of disease
by: Jordan Sugarman, BSc, et al.
Published: (2014) -
Estimating the global burden of endemic canine rabies.
by: Katie Hampson, et al.
Published: (2015)